A study by researchers at NewYork-Presbyterian/Columbia University Medical Center and published in JACC: Heart Failure, a journal of the American College of Cardiology Foundation, allays concerns among cardiologists that aspirin could increase the risk of hospitalization and death related to heart failure for patients with heart failure who take one of the first-line therapies: angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).

Dr. Virendra Patel has been named chief of the Division of Vascular Surgery and Endovascular Interventions and co-director of the Aortic Program at NewYork-Presbyterian/Columbia University Irving Medical Center, and an associate professor of surgery at Columbia University Medical Center (CUMC), effective July 1.

Telemedicine initiatives at NewYork-Presbyterian are reducing wait times during emergency hospital visits and enabling neurologists to reach stroke victims across the city more quickly, as described in a new paper.

A new era of community-based healthcare was ushered in with the ribbon-cutting of a state-of-the-art surgical and oncology pavilion at NewYork-Presbyterian Lawrence Hospital. Top hospital administrators, medical staff, and community and government leaders toured the new 36,000-square-foot space to learn about services offered at NewYork-Presbyterian Lawrence.

“We are honored to be recognized by Fast Company alongside some of the most innovative leaders in the technology industry,” Dr. Peter Fleischut, senior vice president and chief transformation officer at NewYork-Presbyterian. “We believe that investing in health information technology and innovation are critical to the future of healthcare and helps us put patients first at NewYork-Presbyterian. Our goal with NYP OnDemand is to help patients take better control of their health, with the ease and convenience of virtual, on-the-go access to NewYork-Presbyterian’s world-class medical care.”

NewYork-Presbyterian and content agency, Pace, received two awards for HealthMatters.nyp.org, the Hospital’s new digital storytelling platform. Health Matters won “Best Series of Articles” and “Best New Digital Publication - Design” at the Content Marketing Awards, the largest and longest-running international content marketing awards program in the world.

Scientific innovator and physician Dr. Pawel Muranski has joined NewYork-Presbyterian and Columbia University Medical Center (CUMC) as director of cellular immunotherapy at the newly established Good Manufacturing Practices (GMP) cell production lab and assistant director of Transfusion Medicine and Cellular Therapy. He will also serve on the faculty of CUMC as Assistant Professor of Medicine, Pathology and Cell Biology, a principal investigator at Columbia Center for Translational Immunology (CCTI) and a member of Columbia’s Herbert Irving Comprehensive Cancer Center